117 related articles for article (PubMed ID: 2523170)
1. T-helper lymphocytes and syngeneic graft-versus-host disease.
Bos GM; Majoor GD; van de Gaar MJ; van Breda Vriesman PJ
Transplant Proc; 1989 Feb; 21(1 Pt 3):3016-7. PubMed ID: 2523170
[No Abstract] [Full Text] [Related]
2. Cyclosporin A induces a selective, reversible suppression of T-helper lymphocyte regeneration after syngeneic bone marrow transplantation: association with syngeneic graft-versus-host disease in rats.
Bos GM; Majoor GD; van Breda Vriesman PJ
Clin Exp Immunol; 1988 Dec; 74(3):443-8. PubMed ID: 2976623
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation in the rat. V. Lymphoid cell subclasses in the target organs during acute graft-versus-host disease.
Renkonen R
Transplantation; 1986 Jun; 41(6):704-8. PubMed ID: 2940737
[TBL] [Abstract][Full Text] [Related]
4. Age-related factors in the induction of syngeneic GVHD.
Fischer AC; Beschorner WE; Hess AD
Transplant Proc; 1989 Feb; 21(1 Pt 3):3033-5. PubMed ID: 2650419
[No Abstract] [Full Text] [Related]
5. Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets.
Fischer AC; Laulis MK; Horwitz L; Beschorner WE; Hess A
J Immunol; 1989 Aug; 143(3):827-32. PubMed ID: 2526175
[TBL] [Abstract][Full Text] [Related]
6. Regulation of syngeneic graft-versus-host disease by autosuppressor mechanisms.
Hess AD; Fischer AC; Beschorner WE
Transplant Proc; 1989 Feb; 21(1 Pt 3):3013-5. PubMed ID: 2523169
[No Abstract] [Full Text] [Related]
7. Syngeneic graft-versus-host disease after allogeneic bone marrow transplantation and cyclosporine treatment.
Hess AD; Vogelsang GB; Silanskis M; Friedman KA; Beschorner WE; Santos GW
Transplant Proc; 1988 Jun; 20(3 Suppl 3):487-92. PubMed ID: 3291285
[No Abstract] [Full Text] [Related]
8. Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease.
Tutschka PJ; Berkowitz SD; Tuttle S; Klein J
Transplant Proc; 1987 Feb; 19(1 Pt 3):2668-73. PubMed ID: 3547945
[No Abstract] [Full Text] [Related]
9. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
[TBL] [Abstract][Full Text] [Related]
10. Helper T-lymphocyte precursor frequencies predict risks of graft-versus-host disease in bone marrow transplantation.
Batchelor JR; Schwarer AP; Yin ZJ; Barrett AJ; Goldman JM; Lechler RI
Transplant Proc; 1993 Feb; 25(1 Pt 2):1237-8. PubMed ID: 8442100
[No Abstract] [Full Text] [Related]
11. Rat cytomegalovirus can be transferred by bone marrow cells but does not affect the course of acute graft-versus-host disease.
Bos GM; Majoor GD; Bruggeman CA; Grauls G; van de Gaar MJ; van Breda Vriesman PJ
Transplant Proc; 1989 Feb; 21(1 Pt 3):3050-2. PubMed ID: 2539684
[No Abstract] [Full Text] [Related]
12. Induction of autologous graft-versus-host disease.
Vogelsang GB; Jones RJ; Hess AD; Geller R; Schucter L; Santos GW
Transplant Proc; 1989 Feb; 21(1 Pt 3):2997-8. PubMed ID: 2650411
[No Abstract] [Full Text] [Related]
13. The impact of major histocompatibility complex (MHC) and non-MHC antigenic differences on graft-versus-host disease mediated by helper T cells.
Thiele DL; Lipsky PE
Trans Assoc Am Physicians; 1989; 102():59-67. PubMed ID: 2534709
[No Abstract] [Full Text] [Related]
14. Protection from graft-versus-host disease in fully allogeneic chimeras by prior administration of T cell-depleted syngeneic bone marrow.
Sykes M; Chester CH; Sachs DH
Transplantation; 1988 Aug; 46(2):327-30. PubMed ID: 3043787
[No Abstract] [Full Text] [Related]
15. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
16. Regeneration of lymphocyte subpopulations after bone marrow transplantation: a study with monoclonal antibodies of the BL-series.
Pönisch W; Leiblein S; Friedrich T; Schwenke H; Helbig W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):527-30. PubMed ID: 2480302
[No Abstract] [Full Text] [Related]
17. Analysis of V beta T-cell receptor repertoire of effector mechanisms in acute and chronic graft versus host disease.
Fischer AC; Ruvolo PP; Horwitz LR; Hess AD
Transplant Proc; 1995 Feb; 27(1):1366-9. PubMed ID: 7878914
[No Abstract] [Full Text] [Related]
18. Cyclosporin-induced autoimmunity: a role for marrow-derived cells presenting self antigens in the thymus.
Babcock SK; Georgiu H; Kotzin B; Bellgau D
Transplant Proc; 1989 Feb; 21(1 Pt 1):220-1. PubMed ID: 2650108
[No Abstract] [Full Text] [Related]
19. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
Hess AD; Horwitz LR; Laulis MK
Transplant Proc; 1993 Feb; 25(1 Pt 2):1218-21. PubMed ID: 8442094
[No Abstract] [Full Text] [Related]
20. Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.
Hess AD; Fischer AC; Horwitz L; Bright EC; Laulis MK
J Immunol; 1994 Jul; 153(1):400-11. PubMed ID: 8207251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
